⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AI Visibility Scorecard
REACH CDM: A clinical study for Congenital Myotonic Dystrophy (Congenital DM1)
reachcdm.com · Healthcare
Borderline visible. AI bots can crawl REACH CDM: A clinical study for Congenital Myotonic Dystrophy (Congenital DM1), but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
Monitoring for AI engine activity
In the Engagemii AEO index
#758,934 of 838,764 in Healthcare for AI visibility
3.2
/10
AEO Score
About REACH CDM: A clinical study for Congenital Myotonic Dystrophy (Congenital DM1)
from our crawl and measurement
REACH CDM: A clinical study for Congenital Myotonic Dystrophy (Congenital DM1) is a business whose own site puts it this way: "The REACH CDM Phase 3 study is evaluating the safety and efficacy of AMO-02, or tideglusib, an investigational therapy for children and adolescents living with congenital myotonic dystrophy." When AI engines look at it, they find little to work with. It scores 3.2 out of 10.
The site is missing structured data describing the business, an llms.txt file and a sitemap.
The 6 signals AI reads
Higher is better · 0-10
Structured Data
2
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
7
Clear headings and answer-style content.
Entity Clarity
4
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
1
Experience, Expertise, Authority, Trust markers.
Technical AEO
5
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
6
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
0
No inbound links found yet.
Domain Authority
0
Little domain authority yet.
Reference Presence
0
Not in AI knowledge graphs yet.
News & Press
0
No press coverage found yet.
Community
0
No community discussion yet.
Social Mentions
0
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 3.2/10, REACH CDM: A clinical study for Congenital Myotonic Dystrophy (Congenital DM1) is crawlable but under-signaled - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for REACH CDM: A clinical study for Congenital Myotonic Dystrophy (Congenital DM1)
Which AI engines already crawl you
Weekly ChatGPT & Claude citation tracking
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for REACH CDM: A clinical study for Congenital Myotonic Dystrophy (Congenital DM1).
Source & Attribution
Scored by Engagemii on August 21, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/reachcdm
Cite this score: Engagemii (2026). "AEO Score for REACH CDM: A clinical study for Congenital Myotonic Dystrophy (Congenital DM1)." Retrieved from https://engagemii.com/aeo/brands/reachcdm
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform